Lumbar RF sympatholysis can be conducted at the body of L3 classically or the lower part of L2. Multiple lesions can produce up to 75% relief for 8 weeks. [ 47 ] ...

The SPRINT PNS System is indicated for up to 60 days for: Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; symptomatic relief of post-traumatic pain; ...

BioRestorative receives FDA Fast Track designation for BRTX-100 chronic lumbar disc disease program. News release. BioRestorative Therapies. February 20, 2025.

Building on a growing body of positive data, BioRestorative was granted authorization by the Food and Drug Administration to conduct a Phase 2 clinical trial to treat chronic lumbar disc disease.

VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated using a single intradiscal injection of VIA Disc NP, an allogeneic ...

BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD ...

When it comes to treating back pain, particularly chronic lumbar disc disease (cLDD), the industry is falling short. Sure there's surgery, but that’s an invasive option that isn't always a success.

In October 2024, Dr. Cuéllar performed a three-level lumbar artificial disc replacement (ADR) using the ProDisc system. The procedure involved disc arthroplasty at the L3-4, L4-5, and L5-S1 levels.